Free Trial
NYSEAMERICAN:MAIA

MAIA Biotechnology (MAIA) Stock Price, News & Analysis

MAIA Biotechnology logo
$1.58 +0.02 (+1.28%)
Closing price 08/15/2025 04:10 PM Eastern
Extended Trading
$1.56 -0.02 (-1.27%)
As of 08/15/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MAIA Biotechnology Stock (NYSEAMERICAN:MAIA)

Key Stats

Today's Range
$1.54
$1.64
50-Day Range
$1.48
$2.01
52-Week Range
$1.40
$3.74
Volume
93,707 shs
Average Volume
419,413 shs
Market Capitalization
$52.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MAIA Biotechnology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

MAIA MarketRank™: 

MAIA Biotechnology scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for MAIA Biotechnology.

  • Earnings Growth

    Earnings for MAIA Biotechnology are expected to decrease in the coming year, from ($1.30) to ($1.35) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MAIA Biotechnology is -2.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MAIA Biotechnology is -2.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MAIA Biotechnology has a P/B Ratio of 13.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.25% of the float of MAIA Biotechnology has been sold short.
  • Short Interest Ratio / Days to Cover

    MAIA Biotechnology has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MAIA Biotechnology has recently increased by 75.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MAIA Biotechnology does not currently pay a dividend.

  • Dividend Growth

    MAIA Biotechnology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.25% of the float of MAIA Biotechnology has been sold short.
  • Short Interest Ratio / Days to Cover

    MAIA Biotechnology has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MAIA Biotechnology has recently increased by 75.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MAIA Biotechnology has a news sentiment score of -0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MAIA Biotechnology this week, compared to 1 article on an average week.
  • Search Interest

    5 people have searched for MAIA on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • MarketBeat Follows

    9 people have added MAIA Biotechnology to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MAIA Biotechnology insiders have bought more of their company's stock than they have sold. Specifically, they have bought $50,000.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    32.32% of the stock of MAIA Biotechnology is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.65% of the stock of MAIA Biotechnology is held by institutions.

  • Read more about MAIA Biotechnology's insider trading history.
Receive MAIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MAIA Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

MAIA Stock News Headlines

MAIA Biotechnology (MAIA) to Release Quarterly Earnings on Friday
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

MAIA Stock Analysis - Frequently Asked Questions

MAIA Biotechnology's stock was trading at $2.09 on January 1st, 2025. Since then, MAIA shares have decreased by 24.4% and is now trading at $1.58.

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) posted its earnings results on Tuesday, November, 12th. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.32) by $0.21.

Top institutional shareholders of MAIA Biotechnology include Centric Wealth Management (1.89%), Geode Capital Management LLC (0.73%), Jane Street Group LLC (0.09%) and Marshall Wace LLP (0.05%). Insiders that own company stock include Stan Smith, Ngar Yee Louie, Vlad Vitoc, Cristian Luput, Ramiro Guerrero and Joseph F Mcguire.
View institutional ownership trends
.

Shares of MAIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MAIA Biotechnology investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Jabil (JBL), Adobe (ADBE) and AppLovin (APP).

Company Calendar

Last Earnings
11/12/2024
Today
8/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:MAIA
CIK
1878313
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$23.25 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-497.29%
Return on Assets
-165.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.19
Quick Ratio
2.35

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.12 per share
Price / Book
13.17

Miscellaneous

Outstanding Shares
32,990,000
Free Float
22,330,000
Market Cap
$52.12 million
Optionable
Not Optionable
Beta
0.01
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NYSEAMERICAN:MAIA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners